| Audrey Merrill Garrett, MD | |
|
33 Whiting Hill Rd, Suite 21, Brewer, ME 04412-1021 | |
| (207) 973-7478 | |
| (207) 973-8707 |
| Full Name | Audrey Merrill Garrett |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 35 Years |
| Location | 33 Whiting Hill Rd, Brewer, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467483859 | NPI | - | NPPES |
| MM596802 | Other | ME | MEDICARE B - BLUE HILL MEMORIAL HOSPITAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 013988 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Eastern Maine Medical Center | Bangor, ME | Hospital |
| Northern Light Maine Coast Hospital | Ellsworth, ME | Hospital |
| St Joseph Hospital | Bangor, ME | Hospital |
| Northern Light Blue Hill Memorial Hospital | Blue hill, ME | Hospital |
| Sebasticook Valley Health | Pittsfield, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eastern Maine Medical Center | 2062315161 | 577 |
| Maine Coast Regional Health Facilities | 1052208113 | 88 |
News Archive
The Germans Trias i Pujol Health Sciences Research Institute and the Universitat Autònoma de Barcelona have discovered the first genetic biomarker to detect Lewy body dementia, a disease that can be confused with Alzheimer's.
The U.S. Food and Drug Administration today approved the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System, the first implant system marketed in the U.S. for adults who have transfemoral—or above-the-knee—amputations and who have or are anticipated to have rehabilitation problems with, or cannot use, a conventional socket prosthesis.
Enable Injections, Inc., a company developing and manufacturing investigational wearable infusion devices for combination products, today announced it has entered into a development agreement with Genentech, a member of the Roche Group. The enFuseTM, under development by Enable, will enable patient-administered subcutaneous delivery of high-volume therapeutics.
Yale experts and their partners in a national research consortium have identified several genes and gene clusters associated with the immune response to flu vaccination.
Colorectal cancer, commonly called colon cancer, is the third most common cancer and the third leading cause of cancer death in the United States. Research, published today, by the American Cancer Society shows that the incidence of colorectal cancer among adults aged 50 years or more has fallen by 30% in the US over the last 10 years. This is thought to be primarily due to the widespread uptake of colonoscopy screening, which has almost tripled among adults aged 50 to 75 years (19% in 2000; 55% in 2010).
› Verified 4 days ago
| Entity Name | Eastern Maine Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790789147 PECOS PAC ID: 2062315161 Enrollment ID: O20040128000088 |
News Archive
The Germans Trias i Pujol Health Sciences Research Institute and the Universitat Autònoma de Barcelona have discovered the first genetic biomarker to detect Lewy body dementia, a disease that can be confused with Alzheimer's.
The U.S. Food and Drug Administration today approved the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System, the first implant system marketed in the U.S. for adults who have transfemoral—or above-the-knee—amputations and who have or are anticipated to have rehabilitation problems with, or cannot use, a conventional socket prosthesis.
Enable Injections, Inc., a company developing and manufacturing investigational wearable infusion devices for combination products, today announced it has entered into a development agreement with Genentech, a member of the Roche Group. The enFuseTM, under development by Enable, will enable patient-administered subcutaneous delivery of high-volume therapeutics.
Yale experts and their partners in a national research consortium have identified several genes and gene clusters associated with the immune response to flu vaccination.
Colorectal cancer, commonly called colon cancer, is the third most common cancer and the third leading cause of cancer death in the United States. Research, published today, by the American Cancer Society shows that the incidence of colorectal cancer among adults aged 50 years or more has fallen by 30% in the US over the last 10 years. This is thought to be primarily due to the widespread uptake of colonoscopy screening, which has almost tripled among adults aged 50 to 75 years (19% in 2000; 55% in 2010).
› Verified 4 days ago
| Entity Name | Maine Coast Regional Health Facilities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740249739 PECOS PAC ID: 1052208113 Enrollment ID: O20040804001405 |
News Archive
The Germans Trias i Pujol Health Sciences Research Institute and the Universitat Autònoma de Barcelona have discovered the first genetic biomarker to detect Lewy body dementia, a disease that can be confused with Alzheimer's.
The U.S. Food and Drug Administration today approved the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System, the first implant system marketed in the U.S. for adults who have transfemoral—or above-the-knee—amputations and who have or are anticipated to have rehabilitation problems with, or cannot use, a conventional socket prosthesis.
Enable Injections, Inc., a company developing and manufacturing investigational wearable infusion devices for combination products, today announced it has entered into a development agreement with Genentech, a member of the Roche Group. The enFuseTM, under development by Enable, will enable patient-administered subcutaneous delivery of high-volume therapeutics.
Yale experts and their partners in a national research consortium have identified several genes and gene clusters associated with the immune response to flu vaccination.
Colorectal cancer, commonly called colon cancer, is the third most common cancer and the third leading cause of cancer death in the United States. Research, published today, by the American Cancer Society shows that the incidence of colorectal cancer among adults aged 50 years or more has fallen by 30% in the US over the last 10 years. This is thought to be primarily due to the widespread uptake of colonoscopy screening, which has almost tripled among adults aged 50 to 75 years (19% in 2000; 55% in 2010).
› Verified 4 days ago
| Entity Name | Mount Desert Island Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790764512 PECOS PAC ID: 0941250963 Enrollment ID: O20050127000611 |
News Archive
The Germans Trias i Pujol Health Sciences Research Institute and the Universitat Autònoma de Barcelona have discovered the first genetic biomarker to detect Lewy body dementia, a disease that can be confused with Alzheimer's.
The U.S. Food and Drug Administration today approved the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System, the first implant system marketed in the U.S. for adults who have transfemoral—or above-the-knee—amputations and who have or are anticipated to have rehabilitation problems with, or cannot use, a conventional socket prosthesis.
Enable Injections, Inc., a company developing and manufacturing investigational wearable infusion devices for combination products, today announced it has entered into a development agreement with Genentech, a member of the Roche Group. The enFuseTM, under development by Enable, will enable patient-administered subcutaneous delivery of high-volume therapeutics.
Yale experts and their partners in a national research consortium have identified several genes and gene clusters associated with the immune response to flu vaccination.
Colorectal cancer, commonly called colon cancer, is the third most common cancer and the third leading cause of cancer death in the United States. Research, published today, by the American Cancer Society shows that the incidence of colorectal cancer among adults aged 50 years or more has fallen by 30% in the US over the last 10 years. This is thought to be primarily due to the widespread uptake of colonoscopy screening, which has almost tripled among adults aged 50 to 75 years (19% in 2000; 55% in 2010).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Audrey Merrill Garrett, MD 43 Whiting Hill Rd, Ste 300, Brewer, ME 04412-1005 Ph: (207) 973-5035 | Audrey Merrill Garrett, MD 33 Whiting Hill Rd, Suite 21, Brewer, ME 04412-1021 Ph: (207) 973-7478 |
News Archive
The Germans Trias i Pujol Health Sciences Research Institute and the Universitat Autònoma de Barcelona have discovered the first genetic biomarker to detect Lewy body dementia, a disease that can be confused with Alzheimer's.
The U.S. Food and Drug Administration today approved the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System, the first implant system marketed in the U.S. for adults who have transfemoral—or above-the-knee—amputations and who have or are anticipated to have rehabilitation problems with, or cannot use, a conventional socket prosthesis.
Enable Injections, Inc., a company developing and manufacturing investigational wearable infusion devices for combination products, today announced it has entered into a development agreement with Genentech, a member of the Roche Group. The enFuseTM, under development by Enable, will enable patient-administered subcutaneous delivery of high-volume therapeutics.
Yale experts and their partners in a national research consortium have identified several genes and gene clusters associated with the immune response to flu vaccination.
Colorectal cancer, commonly called colon cancer, is the third most common cancer and the third leading cause of cancer death in the United States. Research, published today, by the American Cancer Society shows that the incidence of colorectal cancer among adults aged 50 years or more has fallen by 30% in the US over the last 10 years. This is thought to be primarily due to the widespread uptake of colonoscopy screening, which has almost tripled among adults aged 50 to 75 years (19% in 2000; 55% in 2010).
› Verified 4 days ago
Zarah Dulce Francisco Lucas, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 33 Whiting Hill Rd, Suite 21, Brewer, ME 04412 Phone: 207-973-7478 Fax: 207-973-7807 | |
Alexander Hoi Ki Wu, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 33 Whiting Hill Rd, Brewer, ME 04412 Phone: 207-973-7000 | |
Astrid C Andreescu, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 33 Whiting Hill Rd Ste 21, Brewer, ME 04412 Phone: 207-973-7478 Fax: 207-973-7807 | |
Mrs. Stephanie Lynne Bosse, FNP Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 33 Whiting Hill Rd Ste 300, Brewer, ME 04412 Phone: 207-973-7478 | |
Diana C Porter, FNP Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 33 Whiting Hill Rd, Suite 21, Brewer, ME 04412 Phone: 207-973-7478 Fax: 207-973-7807 | |
Sarah Sinclair, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 33 Whiting Hill Rd, Suite 21, Brewer, ME 04412 Phone: 207-973-7478 Fax: 207-973-7807 |